| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-16 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-12 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-11 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-10 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-10 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-09 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-09 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |